Ascelia Pharma Stock

Ascelia Pharma Liabilities

The The Liabilities of Ascelia Pharma (ACE.ST) as of Aug 1, 2026 is 12.47 M SEK. In the previous year, The Liabilities was 61.98 M SEK — a change of -79.88% (lower).

Liabilities

12.47 MSEK

YoY

-79.88%

Last updated:

In 2026, Ascelia Pharma's total liabilities amounted to 12.47 M SEK, a -79.88% difference from the 61.98 M SEK total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Ascelia Pharma Stock analysis

What does Ascelia Pharma do? Ascelia Pharma is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Ascelia Pharma's Liabilities

Ascelia Pharma's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ascelia Pharma's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Ascelia Pharma's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Ascelia Pharma's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Ascelia Pharma’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Ascelia Pharma stock

The Liabilities of Ascelia Pharma is 12.47 M SEK in 2026.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Ascelia Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Ascelia Pharma